Non Hodgkin's Lymphoma News and Research

RSS
The Non-Hodgkin lymphomas (NHLs) are a diverse group of hematologic cancers which encompass any lymphoma other than Hodgkin's Lymphoma.
New technique for improving medical diagnosis for cancer patients

New technique for improving medical diagnosis for cancer patients

Drugs in the pipeline: new therapies that could change treatment strategies

Drugs in the pipeline: new therapies that could change treatment strategies

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

Proteolix's Carfilzomib granted orphan drug designation

Proteolix's Carfilzomib granted orphan drug designation

Hairdressers at an increased risk for cancers

Hairdressers at an increased risk for cancers

Researchers find benefit for lymphoma patients in combined PET-CT scanning

Researchers find benefit for lymphoma patients in combined PET-CT scanning

Survival rates for patients for with non-Hodgkin lymphoma improved over past decade

Survival rates for patients for with non-Hodgkin lymphoma improved over past decade

Extra-hepatic manifestation of hepatitis C virus infection

Extra-hepatic manifestation of hepatitis C virus infection

Study to look at effect of high dose vitamin C on non-Hodgkin lymphoma patients

Study to look at effect of high dose vitamin C on non-Hodgkin lymphoma patients

Mild chemo before stem cell transplant causes long-term remission of follicular lymphoma

Mild chemo before stem cell transplant causes long-term remission of follicular lymphoma

UK study looks at obesity in women

UK study looks at obesity in women

Cancer risks for overweight women

Cancer risks for overweight women

Vitamin D protects against colorectal cancer

Vitamin D protects against colorectal cancer

Quantitative PET imaging finds early determination of effectiveness of cancer treatment

Quantitative PET imaging finds early determination of effectiveness of cancer treatment

Re-engineered human T cells effectively target and kill cancerous B cells

Re-engineered human T cells effectively target and kill cancerous B cells

FDA grants orphan drug designation to TREANDA

FDA grants orphan drug designation to TREANDA

Rapamycin study is first stage in development of new treatment

Rapamycin study is first stage in development of new treatment

Genta and Emisphere Technologies file investigational new drug exemption

Genta and Emisphere Technologies file investigational new drug exemption

Study looks at cancer incidence among recipients of blood from donors

Study looks at cancer incidence among recipients of blood from donors

Blood transfusions not likely to spread cancer

Blood transfusions not likely to spread cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.